XNK Therapeutics Enters into Research Agreement with Global Pharma Company ...Middle East

PR Newswire - News
HUDDINGE, Sweden, May 4, 2023 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced that the company's autologous natural killer (NK) cell therapy candidate XNK04 will be evaluated in combination with an ADCC competent PD-L1 inhibitor in liver cancer under a research agreement with...

Read More Details
Finally We wish PressBee provided you with enough information of ( XNK Therapeutics Enters into Research Agreement with Global Pharma Company )

Apple Storegoogle play

Also on site :



Latest News